Ying Tian
-
- Lipid metabolism and disorders 4
- Cardiovascular Function and Risk Factors 3
- Atrial Fibrillation Management and Outcomes 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Cancer Genomics and Diagnostics 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Colorectal Cancer Treatments and Studies 4
-
- Lung Cancer Treatments and Mutations 3
- Cited by
- Cardiology and Cardiovascular MedicineEndocrinology, Diabetes and MetabolismCancer Research
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Ying Tian
23 papers receiving 320 citations
Peers
Comparison fields: 5 of 82
- Cardiology and Cardiovascular Medicine 109
- Endocrinology, Diabetes and Metabolism 54
- Cancer Research 32
- Immunology 41
- Pathology and Forensic Medicine 33
Countries citing papers authored by Ying Tian
This map shows the geographic impact of Ying Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Tian more than expected).
Fields of papers citing papers by Ying Tian
This network shows the impact of papers produced by Ying Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Tian. The network helps show where Ying Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 8 | |
| 11 | 2021 | 100 | |
| 12 | 2019 | 51 | |
| 13 | 2018 | 13 | |
| 14 | 2013 | 2 | |
| 15 | 2013 | 4 | |
| 16 | 2011 | 7 | |
| 17 | 2009 | 11 | |
| 18 | Relationship between subclasses of serum HDL and LPL gene HindIII polymorphism in hyperlipidemia | 2005 | 1 |
| 19 | 2005 | 19 | |
| 20 | 2005 | 31 |
About Ying Tian
Ying Tian is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Oncology, having authored 28 papers that have together received 324 indexed citations. Recurring topics across this work include Lipid metabolism and disorders (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cardiovascular Function and Risk Factors (3 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (109 citations), Endocrinology, Diabetes and Metabolism (54 citations) and Cancer Research (32 citations). Ying Tian has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Wei Chen, Shao-Xin Gong, Na Liang, Aiping Wang, Wenqian Huang, Yanhua Xu, Mingde Fu, Bingyu Yan, Tongtong Cao and Brian N. Finck. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.